Pierre Véronneau is a member of Luqa Pharmaceuticals board of Directors since 2012. Pierre has an established experience base which stretches across the major markets of the world through his career as a consulting strategist and as a business developer or with the pharmaceutical companies Almirall and DuPont.
At Almirall, he spearheaded the Licensing and M&A strategy of the company up to the end of 2010. Under his serial licensor leadership, a first ever, transformational, Pan-EU license was secured plus several other important deals were signed. Prior to this role, he was the first General Manager of Almirall¹s newly acquired inhalation technology R&D centre in Germany. When joining the company in 2002, he led a small group of talented licensing professionals, closing deals on 4 continents and managing over 60 partnerships.
Pierre joined the pharmaceutical industry when he was recruited by DuPont Pharma Canada in the late 80’s as a sales representative. He served in various roles of increasing responsibility at local and regional levels before holding national sales, business development and operations leadership at the Canadian headquarters in Toronto.
Pierre is a graduate of the Canadian Forces Officer Candidate School program and the Canadian Army Command and Staff College. He also holds a MBA (Executive) from Concordia University in Montréal. Pierre has both Canadian and French nationalities, and currently lives in Spain.